02 August 2021
Visiongain has published a new report entitled the 3D Printing for Healthcare Market Report 2021-2031: Forecasts by Material (Polymers, Metals, Ceramics, Biological Materials/Cells, Other), by Technology (Stereolithography (SLA), Fused Deposition Modelling, Selective Laser Sintering, Vat Photopolymerization, Material Extrusion, Other), by Application (Anatomical Modeling, Surgical Planning, Precision Prosthetics, Permanent Implants, Active & Wearable Devices, Bioprinting/Tissue Fabrication), by Manufacturer Type (Device Manufacturers, Contract Manufacturers, Point-of-Care Manufacturers, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading 3D Printing for Healthcare Companies AND COVID-19 Recovery Scenarios.
The global 3D printing for healthcare market was valued at US$xx million in 2020 and is projected to grow at a CAGR of xx% during the forecast period 2021-2031. The growing use of this technology in many applications such as transplantation, drug delivery, 3D printed organs, and many others in the healthcare industry is one of the key drivers in the global 3D Printing in Healthcare Market. The global 3D Printing in Healthcare market is also being driven by rising demand for implant customizations during surgical procedures, as well as rising R&D investments.
Use of 3D Printing to fight the Covid-19 pandemic
Covid-19's rapid spread has placed a strain on healthcare systems around the world, with demand for essential medical equipment and supplies increasing. The Covid-19 crisis has prompted major manufacturers, as well as individuals, to promote the development of critical medical equipment for hospitals. 3D Systems, Carbon, and Renishaw have started developing and producing open-source personal protective equipment (PPE) for healthcare workers all over the world.
How this Report Will Benefit you?
Visiongain’s 520+ page report provides 331 tables and 335 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the global 3D printing for healthcare market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for 3D Printing For Healthcare. Get the financial analysis of the overall market and different segments including technology, material, application, manufacturer type and capture higher market share. We believe that high opportunity remains in this fast-growing 3D printing for healthcare market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report would help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.
What are the current market drivers?
Metals and Alloy Segment is Expected to Grow with High CAGR in the Forecasted Period
Biocompatibility is important for any 3D-printed device that may be used for an implant or other medical application. Surface chemistry, surface topography, and other parameters that drive biological response to the implanted system must all be met by any material used. The most favoured and biocompatible metallic materials for a biomedical implant are titanium alloy and pure titanium. Titanium alloys, such as Ti6Al4V, increase strength and corrosion resistance.
New Technological Advancements drives Adoption of 3D Printing in Healthcare
Technological innovation aids in the development of new 3D-printed products, increasing the demand for 3D printing in the healthcare industry, which is one factor driving the market's growth. Furthermore, the growth of the 3D Printed Medical Devices Market is aided by increased research and development activities, which aid in the development of new treatments for a variety of diseases.
Where are the market opportunities?
Use of 3D Printing In Personalised/ Precision Medicine
Since the implementation of the precision medicine program in the United States in 2015, the individualization of therapeutic services has become increasingly a concern. Innovative preparation technology is 3D printing drug. 3D printing is a highly flexible procedure that can be used to accurately monitor the dosage by defining the pill size or filling percentage to meet individual needs of each patient. In 3D printing, pills of complex structures can be printed to control the releases rate or pills on request can be printed to increase accuracy of dosage.
Streamlined and more efficient R&D processes
The pharmaceutical industry is experiencing a growing R&D crisis, as medicines are failing at ever-later stages. Clinical trials are now using bioprinted tissues and organs to further improve success rates. Researchers may use bioprinting to create completely functioning organs made of human cells to assess the effectiveness of a drug before using in vivo animal or human experiments. This not only eliminates animal suffering, but it also speeds up the entire R&D process.
The major players operating in the 3D printing for healthcare market are Stratasys Ltd., 3D Systems Corporation, Materialise NV, Renishaw plc, Prodways Group SA, SLM Solutions Group AG, Organovo Holdings, Inc., Proto Labs, Inc., Nano Dimension Ltd, ExOne Co, Ekso Bionics Holdings, Inc., Voxeljet AG, ConforMIS, Inc., Tinkerine Studios Ltd., Cellink AB, Aprecia Pharmaceuticals, EnvisionTEC, Cyfuse Biomedical, Cellbricks, Formlabs, These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global biologics market was valued at US$382.85 billion in 2022 and is projected to grow at a CAGR of 8.82% during the forecast period 2022-2032.
04 July 2022
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.